Drug developed using DRDO technology gets DCGI approval

Drug developed using DRDO technology gets DCGI approval

Daily Current Affairs / Drug developed using DRDO technology gets DCGI approval

Change Language English Hindi

Category : Science and Tech Published on: March 18 2023

Share on facebook

A critical drug, 'prussian blue' insoluble formulations developed on a Defence Research and Development Organisation (DRDO) technology recently received approval from the Drugs Controller General of India (DCGI).
It is one of the critical medicines listed by the World Health Organisation for radiological and nuclear emergencies.
It was developed under the Technology Development Fund (TDF).
The drug has been developed based on the technology of the Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, a laboratory of the DRDO.
The formulations are used for the decontamination of Cesium and Thallium.
The drug will be available under the trade name of Pru-DecorpTM and PruDecorp-MG.

Recent Post's

India halts auction of Lord Buddha’s sacred Piprahwa Relics in Hong Kong, sends legal notice to Sotheby’s.
Read More....
UNSC raises concern over Pakistan's missile tests and LeT links in Pahalgam attack.
Read More....
Russia declares May 8–10 ceasefire for WWII Victory Day; Ukraine rejects it as political stunt.
Read More....
C-DOT and CSIR-NPL sign MoU to boost joint research in classical and quantum communication.
Read More....
Cabinet approves revised SHAKTI policy to grant coal linkages to thermal power plants.
Read More....
INS Kiltan joins IMDEX Asia 2025 in Singapore to strengthen India–Singapore maritime ties.
Read More....
Cabinet approves National Scheme for ITI upgradation and five National Skilling Centres.
Read More....
Indian forces conduct 24 precision strikes on Pakistan-based terror infrastructure.
Read More....
Rohit Sharma announces retirement from Test cricket, continues with ODIs.
Read More....
Moody’s lowers India’s 2025 GDP growth forecast to 6.3% citing global headwinds.
Read More....